TY - JOUR
T1 - A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling
AU - Schirone, Leonardo
AU - Forte, Maurizio
AU - Palmerio, Silvia
AU - Yee, Derek
AU - Nocella, Cristina
AU - Angelini, Francesco
AU - Pagano, Francesca
AU - Schiavon, Sonia
AU - Bordin, Antonella
AU - Carrizzo, Albino
AU - Vecchione, Carmine
AU - Valenti, Valentina
AU - Chimenti, Isotta
AU - Falco, Elena De
AU - Sciarretta, Sebastiano
AU - Frati, Giacomo
N1 - Publisher Copyright:
© 2017 Leonardo Schirone et al.
PY - 2017
Y1 - 2017
N2 - Pathological molecular mechanisms involved in myocardial remodeling contribute to alter the existing structure of the heart, leading to cardiac dysfunction. Among the complex signaling network that characterizes myocardial remodeling, the distinct processes are myocyte loss, cardiac hypertrophy, alteration of extracellular matrix homeostasis, fibrosis, defective autophagy, metabolic abnormalities, and mitochondrial dysfunction. Several pathophysiological stimuli, such as pressure and volume overload, trigger the remodeling cascade, a process that initially confers protection to the heart as a compensatory mechanism. Yet chronic inflammation after myocardial infarction also leads to cardiac remodeling that, when prolonged, leads to heart failure progression. Here, we review the molecular pathways involved in cardiac remodeling, with particular emphasis on those associated with myocardial infarction. A better understanding of cell signaling involved in cardiac remodeling may support the development of new therapeutic strategies towards the treatment of heart failure and reduction of cardiac complications. We will also discuss data derived from gene therapy approaches for modulating key mediators of cardiac remodeling.
AB - Pathological molecular mechanisms involved in myocardial remodeling contribute to alter the existing structure of the heart, leading to cardiac dysfunction. Among the complex signaling network that characterizes myocardial remodeling, the distinct processes are myocyte loss, cardiac hypertrophy, alteration of extracellular matrix homeostasis, fibrosis, defective autophagy, metabolic abnormalities, and mitochondrial dysfunction. Several pathophysiological stimuli, such as pressure and volume overload, trigger the remodeling cascade, a process that initially confers protection to the heart as a compensatory mechanism. Yet chronic inflammation after myocardial infarction also leads to cardiac remodeling that, when prolonged, leads to heart failure progression. Here, we review the molecular pathways involved in cardiac remodeling, with particular emphasis on those associated with myocardial infarction. A better understanding of cell signaling involved in cardiac remodeling may support the development of new therapeutic strategies towards the treatment of heart failure and reduction of cardiac complications. We will also discuss data derived from gene therapy approaches for modulating key mediators of cardiac remodeling.
UR - http://www.scopus.com/inward/record.url?scp=85024477401&partnerID=8YFLogxK
U2 - 10.1155/2017/3920195
DO - 10.1155/2017/3920195
M3 - Article
C2 - 28751931
AN - SCOPUS:85024477401
SN - 1942-0900
VL - 2017
JO - Oxidative Medicine and Cellular Longevity
JF - Oxidative Medicine and Cellular Longevity
M1 - 3920195
ER -